Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation

Journal of Human Genetics

Volumn 54, Issue 5, 2009, Pages 277-283

  Yang, Yiqing ^a,b,c,d   Li, Jun ^a,b,c   Lin, Xiaoping ^a   Yang, Yanzong ^e   Hong, Kui ^f   Wang, Lei ^a   Liu, Jinqiu ^e   Li, Li ^d   Yan, Dinghong ^g   Liang, Dandan ^a   Xiao, Junjie ^a,b,c   Jin, Hongmei ^h   Wu, Jie ⁱ   Zhang, Yangyang ^j   Chen, Yi Han ^a,b,c,d  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Heart Rhythm Research Center   (China)

^d TONGJI UNIVERSITY   (China)

^e DALIAN MEDICAL UNIVERSITY   (China)

^f NANCHANG UNIVERSITY   (China)

^g THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^h NANTONG UNIVERSITY   (China)

ⁱ People's Hospital of Haimen   (China)

^j THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

more..

Author keywords

Atrial fibrillation; Electrophysiology; Genetics; Ion channel

Indexed keywords

POTASSIUM CHANNEL KV1.5;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FAMILY; FEMALE; GENETIC IDENTIFICATION; HEART ATRIUM FIBRILLATION; HEREDITY; HUMAN; IDIOPATHIC DISEASE; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; POTASSIUM CURRENT;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ATRIAL FIBRILLATION; BASE SEQUENCE; ELECTROPHYSIOLOGICAL PHENOMENA; FEMALE; GENETIC TESTING; HUMANS; KV1.5 POTASSIUM CHANNEL; MALE; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION; PEDIGREE; PHENOTYPE; SEQUENCE ALIGNMENT; SPECIES SPECIFICITY;

EID: 67649536037     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2009.26     Document Type: Article

References (35)

1. Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V. et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285, 2370-2375 (2001).
2. Lloyd-Jones, D. M., Wang, T. J., Leip, E. P., Larson, M. G., Levy, D., Vasan, R. S. et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110, 1042-1046 (2004).
3. Chugh, S. S., Blackshear, J. L., Shen, W. K., Hammill, S. C. & Gersh, B. J. Epidemiology and natural history of atrial fibrillation: clinical implications. J. Am. Coll. Cardiol. 37, 371-378 (2001).
4. Benjamin, E. J., Wolf, P. A., D'Agostino, R. B., Silbershatz, H., Kannel, W. B. & Levy, D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98, 946-952 (1998).
5. Nattel, S. New ideas about atrial fibrillation 50 years on. Nature 415, 219-226 (2002).
6. Brand, F. N., Abbott, R. D., Kannel, W. B. & Wolf, P. A. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. JAMA 254, 3449-3453 (1985).
7. Fox, C. S., Parise, H., D'Agostino, R. B. Sr, Lloyd-Jones, D. M., Vasan, R. S., Wang, T. J. et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 291, 2851-2855 (2004).
8. Tsai, C. T., Lai, L. P., Hwang, J. J., Lin, J. L. & Chiang, F. T. Molecular genetics of atrial fibrillation. J. Am. Coll. Cardiol. 52, 241-250 (2008).
9. Brugada, R., Tapscott, T., Czernuszewicz, G. Z., Marian, A. J., Iglesias, A., Mont, L. et al. Identification of a genetic locus for familial atrial fibrillation. N. Engl. J. Med. 336, 905-911 (1997).
10. Ellinor, P. T., Shin, J. T., Moore, R. K., Yoerger, D. M. & MacRae, C. A. Locus for atrial fibrillation maps to chromosome 6q14-16. Circulation 107, 2880-2883 (2003).
11. Darbar, D., Hardy, A., Haines, J. & Roden, D. M. Prolonged signal-averaged P-wave duration as an intermediate phenotype for familial atrial fibrillation. J. Am. Coll. Cardiol. 51, 1083-1089 (2008).
12. Chen, Y. H., Xu, S. J., Bendahhou, S., Wang, X. L., Wang, Y., Xu, W. Y. et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 299, 251-254 (2003).
13. Hong, K., Bjerregaard, P., Gussak, I. & Brugada, R. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J. Cardiovasc. Electrophysiol. 4, 394-396 (2005).
14. Darbar, D., Kannankeril, P. J., Donahue, B. S., Kucera, G., Stubblefield, T., Haines, J. L. et al. Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation 117, 1927-1935 (2008).
15. Makiyama, T., Akao, M., Shizuta, S., Doi, T., Nishiyama, K., Oka, Y. et al. A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. J. Am. Coll. Cardiol. 52, 1326-1334 (2008).
16. Mohler, P. J., Schott, J. J., Gramolini, A. O., Dilly, K. W., Guatimosim, S., duBell, W. H. et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421, 634-639 (2003).
17. Xia, M., Jin, Q., Bendahhou, S., He, Y., Larroque, M. M., Chen, Y. et al. A Kir2.1 gainof-function mutation underlies familial atrial fibrillation. Biochem. Biophys. Res. Commun. 332, 1012-1019 (2005).
18. Olson, T. M., Alekseev, A. E., Liu, X. K., Park, S., Zingman, L. V., Bienengraeber, M. et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum. Mol. Genet. 15, 2185-2191 (2006).
19. Gollob, M. H., Jones, D. L., Krahn, A. D., Danis, L., Gong, X. Q., Shao, Q. et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N. Engl. J. Med. 354, 2677-2688 (2006).
20. Lai, L. P., Su, M. J., Yeh, H. M., Lin, J. L., Chiang, F. T., Hwang, J. J. et al. Association of the human minK gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am. Heart J. 144, 485-490 (2002).
21. Yang, Y., Xia, M., Jin, Q., Bendahhou, S., Shi, J., Chen, Y. et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am. J. Hum. Genet. 75, 899-905 (2004).
22. Lundby, A., Ravn, L. S., Svendsen, J. H., Hauns, S., Olesen, S. P. & Schmitt, N. KCNE3 mutation V17M identified in a patient with lone atrial fibrillation. Cell Physiol. Biochem. 21, 47-54 (2008).
23. Zeng, Z., Tan, C., Teng, S., Chen, J., Su, S., Zhou, X. et al. The single nucleotide polymorphisms of I(Ks) potassium channel genes and their association with atrial fibrillation in a Chinese population. Cardiology 108, 97-103 (2007).
24. Ravn, L. S., Aizawa, Y., Pollevick, G. D., Hofman-Bang, J., Cordeiro, J. M., Dixen, U. et al. Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillation. Heart Rhythm 5, 427-435 (2008).
25. Gudbjartsson, D. F., Arnar, D. O., Helgadottir, A., Gretarsdottir, S., Holm, H., Sigurdsson, A. et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 448, 353-357 (2007).
26. Darbar, D., Herron, K. J., Ballew, J. D., Jahangir, A., Gersh, B. J., Shen, W. K. et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J. Am. Coll. Cardiol. 41, 2185-2192 (2003).
27. + current in cultured adult human atrial myocytes. Circ. Res. 80, 572-579 (1997).
28. Naccarelli, G. V., Wolbrette, D. L., Khan, M., Bhatta, L., Hynes, J., Samii, S. et al. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am. J. Cardiol. 91, 15D-26D (2003).
29. Lombardi, F., Borggrefe, M., Ruzyllo, W., Lüderitz, B. & A-COMET-II Investigators Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial. Eur. Heart J. 27, 2224-2231 (2006).
30. Elming, H., Brendorp, B., Pehrson, S., Pedersen, O. D., Kober, L. & Torp-Petersen, C. A benefit-risk assessment of class III antiarrhythmic agents. Expert Opin. Drug. Saf. 3, 559-577 (2004).
31. Yang, Q., Wang, X., Du, L., Li, M. & You, Q. Strategies for atrial fibrillation therapy: focusing on IKur potassium channel. Expert Opin. Ther. Pat. 17, 1443-1456 (2007).
32. Wang, Z., Fermini, B. & Nattel, S. Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1. 5 cloned channel currents. Circ. Res. 73, 1061-1076 (1993).
33. Van Wagoner, D. R., Pond, A. L., McCarthy, P. M., Trimmer, J. S. & Nerbonne, J. M. Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ. Res. 80, 772-781 (1997).
34. Li, G. R., Feng, J., Wang, Z., Fermini, B. & Nattel, S. Adrenergic modulation of ultrarapid delayed rectifier K+ current in human atrial myocytes. Circ. Res. 78, 903-915 (1996).
35. Page, R. L. & Roden, D. M. Drug therapy for atrial fibrillation: where do we go from here? Nat. Rev. Drug. Discov. 4, 899-910 (2005).